Three-Drug immune attack on pancreatic cancer shows promise in early trial
Disease control
Terminated
This study tests the safety and effectiveness of combining three immunotherapy drugs (domvanalimab, zimberelimab, and APX005M) in people with metastatic pancreatic cancer that has spread to other parts of the body. The goal is to see if this combination can help control the cance…
Phase: PHASE1, PHASE2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated May 17, 2026 04:40 UTC